
ALT "I would highly recommend the MHPE program at Queen’s University, especially for any health professional pursuing an academic career. This program is unique in that it embraces collaborative practice and has weaved an indigenous perspective throughout the program. Currently, there is no other program in Canada that offers this!"

ALT Figure: Primary endpoint, secondary endpoint, AST, and ALT results in the ITT population. (A) Percentage of patients with NASH resolution without worsening of fibrosis after lifestyle modification and best medical care, Roux-en-Y gastric bypass, and sleeve gastrectomy in the ITT population. (B) Percentage of patients with improvement in liver fibrosis by at least one stage without worsening of NASH in the lifestyle modification, Roux-en-Y gastric bypass, and sleeve gastrectomy groups in the ITT population. (C) AST concentrations at baseline and at 1-year follow-up in the lifestyle modification, Roux-en-Y gastric bypass, and sleeve gastrectomy groups in the ITT population. (D) ALT concentrations at baseline and at 1-year follow-up in the lifestyle modification, Roux-en-Y gastric bypass, and sleeve gastrectomy groups for the ITT population. ALT=alanine aminotransferase. AST=aspartate aminotransferase. ITT=intention to treat. NASH=non-alcoholic steatohepatitis.






























